You are here

Comprehensive Cancer Control National Partnership Announces New Leadership

Aubrey Villalobos, DrPH, MEd, and Sarah Shafir, MPH will serve as chair and vice-chair of the CCCNP in 2021.

 

ATLANTA (February 8, 2021) -- The Comprehensive Cancer Control National Partnership (CCCNP) is pleased to announce that Aubrey Villalobos, DrPH, MEd, and Sarah Shafir, MPH have been elected as the chair and vice-chair of the CCCNP. In these roles, Villalobos and Shafir will be responsible for providing leadership to the 19 partner organizations that make up the CCCNP.

Dr. Villalobos is a Health Scientist with the Implementation Science (IS) Team in the Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI). She is leading several efforts to advance the involvement of practitioners in IS to enhance the integration of evidence-based guidelines, programs, and policies for cancer control in public health and clinical practice. Before joining the NCI, Dr. Villalobos served as director of cancer control and health equity at the George Washington University Cancer Center, where she supported strategic planning for the center’s community outreach and engagement activities and directed a multi-million-dollar portfolio of sponsored projects providing technical assistance and training to public health and health care professionals. Previously, she served as the cancer education outreach coordinator in the international outreach program at St. Jude Children’s Research Hospital.

“I am humbled to be elected to serve as Chair of the CCCNP and am grateful for the opportunity to collaborate with remarkable leaders from organizations committed to driving cancer control forward, especially in these challenging times,” said Villalobos. “Our success as a partnership is thanks to member organizations and representatives who generously share their time, expertise, and resources to advance national priorities. There is still much work to be done reducing cancer risks, detecting cancers earlier, and supporting wellness for cancer survivors, and we have a greater impact working in unison.”

Ms. Shafir is the Managing Director, National Partnerships and Innovation in the Office of Cancer Research and Implementation with the American Cancer Society. In this role, Ms. Shafir serves as the Principal Investigator (PI) on the Centers for Disease Control and Prevention’s (CDC) Comprehensive Cancer Control Technical Assistance and Training Cooperative Agreement and the PI on the CDC’s Strengthening Hospital Systems Capacity Building for Cancer Prevention and Screening Cooperative Agreement with the Center for State, Tribal, Local and Territorial Support. For nearly 20 years, Ms. Shafir has been engaged in comprehensive cancer control coalition work at both the state and national levels. Ms. Shafir has served on the leadership group of the Comprehensive Cancer Control National Partnership since 2015.

The Comprehensive Cancer Control National Partnership, established in 1998, is a collaborative group of diverse national organizations working together to build and strengthen comprehensive cancer control (CCC) efforts across the nation. Today, the CCCNP is an influential group of leading cancer organizations that utilize their combined strengths and resources to change the trajectory of the cancer burden in the U.S.

As chair and vice-chair, Dr. Villalobos and Ms. Shafir work with the CCCNP Leadership Group to identify opportunities to coordinate across priority areas and member organizations, ensure that the CCCNP structure is optimal for implementing priorities, and provide recommendations to the full CCCNP leadership regarding priority issues, membership requests, and resource needs.

“The CCCNP recently recommitted to an intentional focus on health equity, offering support to cancer coalitions around the country in addressing social and structural factors that influence cancer and other health outcomes, including systemic racism,” Villalobos said. “I’m proud that health equity is integrated across our strategic plan and the activities of each CCCNP priority workgroup.”

 

About the Comprehensive Cancer Control National Partnership

Formed in 1998, the CCCNP consists of 19 leading national cancer organizations that come together to utilize their combined strengths and resources to support and advance the work of comprehensive cancer control coalitions. Two strategic goals guide the work of the CCCNP, including coordinating national comprehensive cancer control efforts and facilitating and providing support to comprehensive cancer control coalitions.

The current focus areas of the CCCNP include:

  • Sustaining effective CCC coalitions in states, tribes and territories
  • Increasing colorectal cancer (CRC) screening to 80% in every community
  • Addressing health behaviors of cancer survivors
  • Addressing vaccine-preventable cancers
  • Advancing health equity

To learn more about the Comprehensive Cancer Control National Partnership, please visit our website at www.cccnationalpartners.org.

 

 

Contact:

Ruvini Samarasinha

pve1@cdc.gov

(404)-498-1819

www.cccnationalpartners.org